Akihiko Sokai, Tomohiro Handa, Toru Oga, Kiminobu Tanizawa, Kohei Ikezoe, Yoshinari Nakatsuka, Takeshi Kubo, Kumiko Kanatani, Kazuo Chin, Michiaki Mishima
Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(3):226-235. doi: 10.36141/svdld.v34i3.5214. Epub 2020 Mar 9.
Generally, a disease-specific health-related quality of life (HRQOL) measurement is more useful than generic measures in assessing perceived physical and mental health characteristic of a particular disease. The idiopathic pulmonary fibrosis (IPF)-specific version of St. George's Respiratory Questionnaire (SGRQ-I) has been recently developed for patients with IPF. We proposed to evaluate associations between the SGRQ-I and other clinical indices, as well as its prognostic value in patients with IPF. Fifty-two patients with IPF were recruited in this prospective cohort study. HRQOL was assessed using the SGRQ-I and the Medical Outcomes Study 36-item Short Form, dyspnea using the modified Medical Research Council (mMRC) dyspnea scale, and psychological status using the Hospital Anxiety and Depression Scale (HADS). We then evaluated the relationship between the SGRQ-I and other clinical measures, as well as one-year clinical deterioration defined as a hospital admission due to respiratory exacerbation or all-cause death. Stepwise multiple-regression analyses revealed that the mMRC dyspnea scale, the HADS anxiety or depression, and minimum oxygen saturation during a six-minute walk test significantly contributed to the Total and three components of the SGRQ-I. In multivariate Cox proportional-hazards analyses, the Total score of SGRQ-I predicted clinical deterioration independent of forced vital capacity, the six-minute walk distance, or partial pressure of arterial oxygen on room air. The SGRQ-I is a multidisciplinary instrument representing physical, functional and psychological impairments in patients with IPF. The SGRQ-I is a significant predictor of short-term disease progression independent of physiological measurements. .
一般来说,在评估特定疾病的感知身心健康特征时,特定疾病的健康相关生活质量(HRQOL)测量比通用测量更有用。最近为特发性肺纤维化(IPF)患者开发了圣乔治呼吸问卷(SGRQ)的IPF特定版本(SGRQ-I)。我们建议评估SGRQ-I与其他临床指标之间的关联,以及其在IPF患者中的预后价值。在这项前瞻性队列研究中招募了52例IPF患者。使用SGRQ-I和医学结果研究36项简表评估HRQOL,使用改良的医学研究委员会(mMRC)呼吸困难量表评估呼吸困难,使用医院焦虑和抑郁量表(HADS)评估心理状态。然后,我们评估了SGRQ-I与其他临床指标之间的关系,以及将因呼吸加重或全因死亡而住院定义为一年临床恶化的情况。逐步多元回归分析显示,mMRC呼吸困难量表、HADS焦虑或抑郁以及六分钟步行试验期间的最低氧饱和度对SGRQ-I的总分和三个组成部分有显著贡献。在多变量Cox比例风险分析中,SGRQ-I的总分可独立于用力肺活量、六分钟步行距离或室内空气中动脉血氧分压预测临床恶化。SGRQ-I是一种代表IPF患者身体、功能和心理损伤的多学科工具。SGRQ-I是独立于生理测量的短期疾病进展的重要预测指标。